Navigation Links
Medical Device Developer Promaxo Closes $3.5 Million Series A Funding Round

Promaxo, Inc., a medical device company developing and commercializing a single-sided MRI, announced today that it has closed a $3.5 million Series A funding, with MicroPort Scientific Corporation as the strategic investor leading the round. As part of the strategic investment, MicroPort will secure exclusive China distribution rights and manufacturing rights of Promaxo’s MRI technology to support China commercialization.

Promaxo will use the new capital, together with $1.4 million in seed funding raised earlier this year, to perform clinical validation and prepare regulatory submission of its office-based high-resolution MRI. The Company’s MRI platform is protected by 33 issued and pending patents, and has been awarded over $9 million in NIH and NSF grants.

Once brought to market, Promaxo’s suite of prostate cancer disease management solutions will transform the screening, diagnosis and treatment of prostate cancer, and improve the lives of millions of men affected by the disease. A video highlighting the Promaxo story and solution is available at:

“We are thrilled to have MicroPort on board as a strategic investor and partner,” stated Promaxo’s CEO and President Amit Vohra, PhD, MBA. “The partnership will allow us to leverage MicroPort’s brand, talents, and global footprint to scale Promaxo’s MRI platform, and bring an office-based MRI to the masses.”

In a separate but related announcement, as part of its strategic growth plan, Promaxo has recently added Diego Olego, PhD, MBA, to the Company’s advisory team. Dr. Olego joined Philips in 1986, and over a career spanning more than three decades held several leadership positions in research, technology and innovation management, including Chief Strategy and Innovation Officer of Philips Healthcare.

"I am excited to be joining the Promaxo team,” stated Dr. Olego. “I believe that Promaxo's mobile innovative MR platform promises broad clinical and workflow impact, especially for prostate cancer patients."

For more information visit or email hello(at)

About Promaxo Inc.

Promaxo is developing and commercializing office-based high-resolution MRI, real time MRI compatible biopsy and treatment tools, and CAD software for tissue characterization. The company is currently focused on transforming the screening, diagnosis and treatment of prostate cancer.

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related biology technology :

1. In’Tech Medical Unveils New Branding Initiative
2. Velico Medical Announces a Further $18.9m BARDA Funding for Spray Dried Alternative to Frozen Plasma
3. Vixiar Medical Taking up Residence at The LaunchPort™ in Port Covington
4. Varicose Veins Myths Highlight the Importance of Understanding Medical Options, says Northwest Vein & Aesthetic Center
5. Pacific Neuroscience Institute Medical Group Joins Providence Saint Johns Health Clinic For Greater Access to Care of Neurological and Cranial Disorders
6. Novel Medical Device Manufacturing Operation and Accelerator Coming to Port Covington
7. Omnia Education Expands its Live Medical Conferences by Adding New U.S. Cities, New Faculty, Interactive Educational Games, and Cutting Edge Clinical Topics
8. CNA Finance Initiates Research Coverage On Advanced Medical Isotope Corporation
9. Brian Pogue Named Editor of Journal of Biomedical Optics
10. Lutheran Medical Center Recognized in Fierce Innovation Awards in Healthcare for its Implementation of BIOVIGIL
11. Kapstone Medical Celebrates 10th Anniversary
Post Your Comments:
(Date:5/8/2019)... ... ... hands, Atlas is on the large side for a Quarter Horse. He and his ... When loping around a corner in late 2017, Atlas tripped and partially tore his ... able to walk. Fortunately Atlas’ owner, Kelly, sought the opinion of her veterinarian, Dr. ...
(Date:5/4/2019)... ... May 03, 2019 , ... ... of the Dakila Pesquisas Association, the scientist and ufologist Urandir Fernandes de Oliveira, ... (DF). Urandir detailed the results of some research carried out by the association, ...
(Date:5/2/2019)... BELTSVILLE, Md. (PRWEB) , ... ... ... certification to the International Organization for Standardization ISO 9001:2015 standard, REPROCELL USA ... consistently meet customer requirements. In addition, REPROCELL USA Inc. aims to enhance ...
(Date:5/2/2019)... , ... May 02, 2019 , ... Stay on top ... medical device and food industries. Access to all webinars is free, so be sure ... in your field! , Visit to see our upcoming webinars: , ...
Breaking Biology Technology:
(Date:6/6/2019)... ... June 05, 2019 , ... ... of a new network station and service center in Mexico City, Mexico. Mexico ... the world — with more than $1.75 billion in pharmaceutical exports since 2015. ...
(Date:6/4/2019)... ... June 04, 2019 , ... Most preclinical EEG visualization ... risk signals, usually based on variations of amplitude, frequency or spike train detection. ... methodology due to the complexity and variability of the signal, and automation tools ...
(Date:5/31/2019)... VIEJO, Calif. (PRWEB) , ... May 30, 2019 ... ... leading clinical genetics testing company, and Mayo Clinic, have documented significant differences in ... cancer among racial and ethnic populations compared to non-Hispanic White women. Results will ...
Breaking Biology News(10 mins):